Disc Medicine, Inc. (IRON)
66.09
-1.17
(-1.74%)
USD |
NASDAQ |
Apr 29, 16:00
66.09
0.00 (0.00%)
After-Hours: 16:03
Disc Medicine Research and Development Expense (TTM) : 170.36M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amylyx Pharmaceuticals, Inc. | 89.88M |
| Eli Lilly & Co. | 13.34B |
| Masimo Corp. | 126.40M |
| Cytokinetics, Inc. | 405.90M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |